the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Microsoft CEO Satya Nadella’s planned visit to Malaysia postponed

Microsoft chief executive officer Satya Nadella’s anticipated visit to Malaysia has been postponed.

In a statement to the media, the company said it was “actively working to secure a new date” for the event.

“As soon as we have the details, we will communicate them. We apologise once again for any inconvenience and appreciate your continued support,“ it said, as reported by The Edge.

Nadella was originally scheduled to make his first official visit to Malaysia for the Microsoft Build: AI Day which aimed to bring technologists together to learn and discuss the latest innovations in the artificial intelligence (AI) space.

Yesterday, it was reported that the government remains committed to collaborating with Microsoft to position the country as the digital hub of Southeast Asia.

Investment, Trade and Industry Minister (MITI) minister Tengku Datuk Seri Zafrul Abdul Aziz said MITI – together with other relevant agencies – is working closely with Microsoft to devise a strategy to achieve this goal.

He posted on X: “The ‘Kekal Bersama Malaysia’ initiative is witnessing a collaboration between Malaysia and Microsoft to make our country the digital hub of ASEAN.

“Looking forward to closer collaboration with Microsoft to drive Malaysia’s leadership in the ASEAN digital sphere,“ he added.

ALSO READ: Tengku Zafrul facilitating PM’s meeting with Microsoft CEO in mission to make Malaysia Asean’s digital hub

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings